Fig. 1From: Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapyTable (a) Two-way scatter plots of VEGF serum levels (n = 96) in HER2+ patients and (b) HER2- patients (n = 108). Trend line along with R2 values is shown for each graphBack to article page